| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |